SCHEMBL21596480

SCHEMBL21596480

CC(C)(C)OC(=O)c1cc(Br)cnc1Cl.CC(C)(C)OC(=O)c1cc(I)cnc1Cl.CC(C)OC(=O)c1cc(Br)cnc1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRK1 P41145 3/20 0.39
P2RX3 P56373 1/20 0.34
AAK1 Q2M2I8 2/20 0.34
MAPT P10636 4/20 0.33
KDM4E B2RXH2 3/20 0.33
ALDH1A1 P00352 2/20 0.33
MEN1 O00255 1/20 0.33
MAPK1 P28482 1/20 0.33
KMT2A Q03164 1/20 0.33
GABRG2 P18507 2/20 0.33
GABRB3 P28472 2/20 0.33
GABRA5 P31644 2/20 0.33
GABRA1 P14867 1/20 0.33
GABRA3 P34903 1/20 0.33
GABRA2 P47869 1/20 0.33
CA12 O43570 2/20 0.31
CA1 P00915 2/20 0.31
CA2 P00918 2/20 0.31
CA7 P43166 2/20 0.31
CA9 Q16790 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21596479 0.84 CA12 (0.41) MAPTKDM4EALDH1A1MEN1KMT2A
SCHEMBL28528395 0.84 GABRG2 (0.41) OPRK1P2RX3ALDH1A1GABRG2GABRB3
SCHEMBL28535766 0.84 OPRK1 (0.48) OPRK1MAPTKDM4EALDH1A1MEN1
SCHEMBL28526753 0.84 ATR (0.38) OPRK1AAK1ALDH1A1GABRG2GABRB3
SCHEMBL4920924 0.71 KDR (0.45) OPRK1MAPTKDM4EALDH1A1GABRG2
SCHEMBL21596476 0.70 OPRK1 (0.40) OPRK1KDM4EALDH1A1MEN1MAPK1
SCHEMBL18044633 0.70 AAK1 (0.38) OPRK1AAK1ALDH1A1GABRG2GABRB3
SCHEMBL1505507 0.69 OPRK1 (0.46) OPRK1KDM4EALDH1A1ATR
SCHEMBL733159 0.69 OPRK1 (0.49) OPRK1
SCHEMBL29149064 0.69 CA12 (0.41) MAPTKDM4EALDH1A1GABRG2GABRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3810585-A1 PROCESS FOR PREPARING TRICYCLIC COMPOUNDS Bayer Aktiengesellschaft (DE) 2021-04-28 EP disclosed
WO-2019243243-A1 PROCESS FOR PREPARING TRICYCLIC COMPOUNDS BAYER AKTIENGESELLSCHAFT (DE) 2019-12-26 WO disclosed